Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$85.37 - $115.44 $7,512 - $10,158
-88 Reduced 1.99%
4,324 $460,000
Q4 2023

Jan 10, 2024

SELL
$69.51 - $104.43 $8,688 - $13,053
-125 Reduced 2.76%
4,412 $438,000
Q3 2023

Oct 17, 2023

BUY
$96.41 - $126.61 $50,711 - $66,596
526 Added 13.11%
4,537 $468,000
Q2 2023

Jul 11, 2023

SELL
$118.5 - $160.53 $513,816 - $696,058
-4,336 Reduced 51.95%
4,011 $487,000
Q1 2023

Apr 12, 2023

BUY
$135.66 - $197.02 $189,652 - $275,433
1,398 Added 20.12%
8,347 $1.28 Million
Q4 2022

Jan 13, 2023

BUY
$118.38 - $210.04 $285,532 - $506,616
2,412 Added 53.16%
6,949 $0
Q3 2022

Oct 13, 2022

SELL
$118.07 - $194.18 $73,911 - $121,556
-626 Reduced 12.12%
4,537 $536,000
Q2 2022

Jul 13, 2022

BUY
$117.13 - $176.59 $22,957 - $34,611
196 Added 3.95%
5,163 $737,000
Q1 2022

Apr 13, 2022

SELL
$126.46 - $235.05 $41,478 - $77,096
-328 Reduced 6.19%
4,967 $856,000
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $146,105 - $238,425
-647 Reduced 10.89%
5,295 $1.35 Million
Q2 2021

Jul 26, 2021

SELL
$129.91 - $234.98 $275,539 - $498,392
-2,121 Reduced 26.31%
5,942 $1.4 Million
Q1 2021

May 03, 2021

BUY
$109.18 - $185.98 $77,081 - $131,301
706 Added 9.6%
8,063 $1.06 Million
Q4 2020

Feb 08, 2021

SELL
$65.74 - $169.86 $147,257 - $380,486
-2,240 Reduced 23.34%
7,357 $769,000
Q3 2020

Oct 13, 2020

BUY
$54.34 - $94.85 $142,642 - $248,981
2,625 Added 37.65%
9,597 $678,000
Q2 2020

Jul 31, 2020

BUY
$29.67 - $80.0 $31,183 - $84,080
1,051 Added 17.75%
6,972 $447,000
Q1 2020

May 12, 2020

BUY
$17.78 - $31.58 $82,925 - $147,289
4,664 Added 371.04%
5,921 $177,000
Q4 2019

Feb 14, 2020

BUY
$13.93 - $21.28 $10,029 - $15,321
720 Added 134.08%
1,257 $25,000
Q3 2019

Oct 22, 2019

BUY
$12.26 - $18.07 $1,532 - $2,258
125 Added 30.34%
537 $8,000
Q1 2019

Apr 15, 2019

BUY
$14.45 - $23.7 $1,907 - $3,128
132 Added 47.14%
412 $8,000
Q4 2018

Jan 28, 2019

BUY
$13.52 - $18.8 $3,785 - $5,264
280 New
280 $4,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.